<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883231</url>
  </required_header>
  <id_info>
    <org_study_id>ARDS mtDNA</org_study_id>
    <nct_id>NCT02883231</nct_id>
  </id_info>
  <brief_title>Plasma Level of Mitochondrial DNA in Patients With ARDS and Its Clinical Significance</brief_title>
  <official_title>Plasma Level of Mitochondrial DNA in Patients With ARDS and Its Clinical Significance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chun Pan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe the changes of plasma mitochondrial DNA (mtDNA) levels in patients with ARDS, and
      to explore its clinical significance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      60 patients who diagnosed as ARDS were included in this study.Then keep blood samples from
      these patients in the first day、the third day and the sveventh day,detect the mitochotndrial
      DNA level in plasma by real-time quantitative PCR. Recored Severity of illness and survival
      status of every patient within 28 days.Objective to evaluate the correlation between the
      level of mitochondrial DNA in plasma and the prognosis of the patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>28-day</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Evaluate the Correlation Between the Level of Mitochondrial DNA in Plasma and the Prognosis of the Patients With ARDS.</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>taking peripheral blood</intervention_name>
    <description>taking peripheral blood of no more than 3ml</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Population admitted to ICU of Zhongda hospital ，diagnosed of ARDS。
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients admitted to ICU diagnosed of ARDS (Berlin criteria),

          2. Patients age between 18 years old and 80 years.

        Exclusion Criteria:

          1. Pregnant women,

          2. Patients with malignant tumor,

          3. Immunosuppression or immunocompromised patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lili Huang, Dr</last_name>
    <phone>13770840246</phone>
    <email>caowangyou007@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haibo Qiu, Dr</last_name>
    <phone>+862583262550</phone>
    <email>haiboq2000@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongda Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lili Huang, Dr</last_name>
      <phone>13770840246</phone>
      <email>caowangyou007@126.com</email>
    </contact>
    <investigator>
      <last_name>Lili Huang, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2016</study_first_submitted>
  <study_first_submitted_qc>August 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2016</study_first_posted>
  <last_update_submitted>August 25, 2016</last_update_submitted>
  <last_update_submitted_qc>August 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Chun Pan</investigator_full_name>
    <investigator_title>attending doctor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

